https://www.avient.com/sites/default/files/2022-02/Sustainability ESG Disclosures_Antimony Trioxide.pdf
CATEGORY DETAIL
EC Number 215-175-0
CAS Number 1309-64-4
Name Subclass 1 Antimony Trioxide (ATO)
Structural Formula
CHEMICAL IDENTITY
PROPERTY DETAIL
Physical State Solid
Form Powder
Color White
Odor Odorless
Melting Point 656°C
Boiling Point 1425°C
Bulk Density 5.20 g/cm3
Water Solubility Slightly Soluble
PHYSICAL/
CHEMICAL
PROPERTIES
HEALTH EFFECTS
HUMAN HEALTH SAFETY ASSESSMENT
Consumer
It is very unlikely that consumers would be exposed to ATO in its concentrated
form because it is only sold for industrial use to make polymers and other products
and is not sold directly to consumers.
https://www.avient.com/sites/default/files/2024-09/Terms and Conditions of Sale for Germany.pdf
Verwendung des Produkts oder (ii) der
Einhaltung oder Nichteinhaltung von Gesetzen
und Vorschriften auf Bundes-, Landes-, Provinz-
oder Kommunalebene ergeben, die diese
Aktivitäten regeln oder kontrollieren.
Buyer shall be exclusively responsible
for (i) ensuring compliance with all Laws
and Standards associated with its
intended use of Product; and (ii)
obtaining all necessary approvals,
permits or clearances for such use.
Buyer shall be exclusively responsible for (i) ensuring compliance with all Laws and Standards associated with its intended use of Product; and (ii) obtaining all necessary approvals, permits or clearances for such use.
https://www.avient.com/sites/default/files/2023-08/Avient General Purchase Conditions.pdf
Unless expressly
stated to the contrary, prices are (i) fixed and
firm (ii) exclusive of any Value Added Tax
(“VAT”) but (iii) inclusive of all other taxes,
duties, levies, fees (including license fees),
labeling, packaging, shipping, charges and
inclusive all costs.
3.2 Avient shall pay the amount invoiced by
Supplier by bank transfer as follows:
3.2.1 North America.
Avient shall not be
responsible for delayed payments in case
invoices are sent by Supplier after the period
under (ii) above.
3.5 Unless otherwise agreed between the
Parties, Supplier will execute the purchasing
process (including but not limited to the
Purchase Order, order confirmation, shipping
notification, invoicing) through electronic
communication.
4.
Avient is entitled to reject
any Goods, which are delivered (i) not at the
agreed time, (ii) not in the agreed volume and/or
quantity, (iii) in inappropriate or damaged
packaging or (iv) with other defect(s), for risk and
account of Supplier and without prejudice to
Avient's right to compensation for the losses and
damages suffered as a result of Supplier’s non-
compliance.
6.
https://www.avient.com/sites/default/files/2022-12/Mevopur Healthcare Bio-based Polymer Solutions Application Bulletin.pdf
KEY CHARACTERISTICS
• Available for polyethylene, polypropylene, ABS,
polycarbonate and styrenics
• Bio-content of resin carrier varies from 70% to
100% depending on polymer—calculated to
ASTM D6866 standard
• Manufactured at four ISO 13485 certified sites,
providing global consistency and security of
supply
• Documented change control beyond CAS
number, reducing risk of change
• Drop-in solutions that can be processed like
fossil-based grades on common injection
molding and extrusion machines
• Can be provided as ready-to-use pre-colored
or additive formulation
REGULATORY SUPPORT
• Raw materials tested to:
- ISO 10993-1
- USP and (incl. class VI)
- European Pharmacopeia, monograph 3.1.3/
3.1.5 (polyolefin packaging materials)
- USP (polyethylene)
- Elemental impurities as per ICH Q3D
• Registered Drug Master File (Type III) and/or
Device Master File
• Food contact according to US FDA and
APPLICATION BULLETIN
Sustainability Spotlight
Bio-polymers
Healthcare use limitations apply—see below.
https://www.avient.com/sites/default/files/2023-03/Mevopur Healthcare Functional Additives Nucleating Application Bulletin.pdf
REGULATORY SUPPORT
• Drug delivery devices
• Pharmaceutical packaging
• Medical equipment
KEY CHARACTERISTICS
• Manufactured at four ISO 13485 certified sites,
providing global consistency and increased
security of supply
• Documented change control beyond CAS
number level, reducing the risk of change
• Allows crystallization in semi-crystalline
polymers to begin faster and complete earlier
REGULATORY SUPPORT
• Raw materials tested to:
- ISO 10993-1 and USP biological
evaluation
- European Pharmacopeia 3.1.3/3.1.5
(polyolefin)
- USP (polyethylene)
- ICH Q3D elemental impurities
• Registered Drug Master File (Type III) and/or
Device Master File
• Food contact established with FDA/EU*
APPLICATION BULLETIN
* FDA/EU compliance information available upon request
Healthcare use limitations apply—see below.
https://www.avient.com/sites/default/files/2023-05/Mevopur Healthcare Colorants and Formulations Amber for Pharma Application Bulletin.pdf
KEY CHARACTERISTICS
• Manufactured at four ISO 13485 certified sites,
providing global consistency and increased
security of supply
• Documented change control beyond CAS
number level, reducing risk of change
• Non-phthalate and formulated without
animal-derived substances
• Different tones of amber available on request
—more or less red or yellow and/or lighter
or darker
• Also available in liquid form
REGULATORY SUPPORT
• Pre-tested raw materials:
- ISO 10993-1 and USP parts
(Class VI)
- European Pharmacopeia, monograph
3.1.15, USP and elemental analysis
as per ICH Q3D
- USP criteria appearance of solution,
color
• Registered Drug Master File (Type III) by
the FDA
• Food contact compliance established with
FDA/EU*
• YBB00102002-2015 (oral liquid pharmaceutical
PET bottles) compliance support
APPLICATION BULLETIN
* FDA/EU compliance
information available
upon request
Healthcare use limitations apply—see below.
https://www.avient.com/sites/default/files/2024-06/EEO Policy Jan 2024.pdf
Any form of discrimination in violation of the provisions of Title VII of the Civil Rights Act of 1964, as
amended, Title I and Title V of the Americans with Disabilities Act of 1990, as amended, The Age
Discrimination in Employment Act of 1967, as amended, and/or Title II of the Genetic Information
Nondiscrimination Act of 2008, or this policy is against the interests of Avient and its employees and
will not be permitted.
https://www.avient.com/sites/default/files/2021-04/eeo-updated-2020.pdf
Any form of discrimination in violation of the provisions of Title VII of the Civil Rights Act of 1964, as
amended, Title I and Title V of the Americans with Disabilities Act of 1990, as amended, The Age
Discrimination in Employment Act of 1967, as amended, and/or Title II of the Genetic Information
Nondiscrimination Act of 2008, or this policy is against the interests of Avient and its employees and
will not be permitted.
https://www.avient.com/sites/default/files/2021-06/maxxam-fr-battery-pack-case-study-one-pager.pdf
https://www.avient.com/resources/safety-data-sheets?page=3441
II
GOLD PEARL II
MI DRIFTWOOD II